Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 2,557.0 | 2,505.9 | 2,391.3 | 2,488.0 | 2,411.8 | 2,271.0 | 2,108.9 | 2,205.7 |
| Revenue growth | 2.0% | 4.8% | -3.9% | 3.2% | 6.2% | 7.7% | -4.4% | -1.7% |
| Cost of goods sold | 1,602.4 | 1,572.6 | 1,550.1 | 1,589.2 | 1,540.6 | 1,470.2 | 1,374.2 | 1,422.4 |
| Gross profit | 954.6 | 933.4 | 841.2 | 898.7 | 871.3 | 800.8 | 734.7 | 783.3 |
| Gross margin | 37.3% | 37.2% | 35.2% | 36.1% | 36.1% | 35.3% | 34.8% | 35.5% |
| Sales and marketing | 121.6 | 117.0 | 109.5 | 120.9 | 126.6 | 121.9 | 113.2 | 121.5 |
| Research and development | 80.8 | 88.5 | 74.8 | 72.5 | 64.5 | 61.4 | 59.4 | 60.8 |
| General and administrative | 324.1 | 326.1 | 303.3 | 301.4 | 306.5 | 292.4 | 265.6 | 290.3 |
| EBITA | 484.4 | 461.8 | 414.6 | 449.0 | 417.2 | 363.5 | 329.9 | 345.4 |
| EBITA margin | 18.9% | 18.4% | 17.3% | 18.0% | 17.3% | 16.0% | 15.6% | 15.7% |
| Amortization of intangibles | 61.0 | 60.0 | 61.0 | 45.0 | 43.6 | 38.4 | 33.4 | 34.8 |
| EBIT | 423.4 | 401.8 | 353.6 | 404.0 | 373.6 | 325.1 | 296.5 | 310.6 |
| EBIT margin | 16.6% | 16.0% | 14.8% | 16.2% | 15.5% | 14.3% | 14.1% | 14.1% |
| Pre-tax income | 389.2 | 354.5 | 263.1 | 396.5 | 356.2 | 299.6 | 268.0 | 275.2 |
| Income taxes | 94.8 | 87.4 | 61.7 | 88.9 | 80.5 | 84.7 | 78.6 | 82.9 |
| Tax rate | 24.4% | 24.6% | 23.4% | 22.4% | 22.6% | 28.3% | 29.3% | 30.1% |
| Earnings from continuing ops | 294.3 | 267.2 | 201.4 | 307.6 | 275.7 | 214.9 | 189.4 | 192.2 |
| Earnings from discontinued ops | | | | | | | 2.1 | 46.8 |
| Net income | 294.3 | 267.2 | 201.4 | 307.6 | 275.7 | 214.9 | 187.3 | 145.5 |
| Net margin | 11.5% | 10.7% | 8.4% | 12.4% | 11.4% | 9.5% | 8.9% | 6.6% |
| |
| Diluted EPS | $7.62 | $6.58 | $4.80 | $7.15 | $6.22 | $4.80 | $4.20 | $4.04 |
| Shares outstanding (diluted) | 38.6 | 40.6 | 42.0 | 43.0 | 44.3 | 44.8 | 45.0 | 47.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|